Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other
miscellaneous service companies in Europe:
Ose Immunotherapeutics SA
sales of 24.46 million Euro [US$27.51 million]
(28.45 million Euro [US$32.00 million]
Brain Biotechnology Research and Information Network AG
based in Germany
(29.05 million Euro [US$32.68 million]
of which 65%
During the year ended December of 2018, sales at
Veloxis Pharmaceuticals A/S were 249.85 million Danish Kroner (US$37.63 million).
increase of 26.8%
versus 2017, when the company's sales were 196.99 million Danish Kroner.
This was the third consecutive year of growth at Veloxis Pharmaceuticals A/S.